FDA Approves Eli Lilly's New Alzheimer's Drug For Early Disease Symptoms

Kisunla, which is the brand name for the drug donanemab-azbt, joins only a handful of other drugs currently approved by the US regulator to treat Alzheimer's, which currently affects more than 6.5 million Americans.

"Kisunla demonstrated very meaningful results for people with early symptomatic Alzheimer's disease," Eli Lilly executive vice president Anne White"We know these medicines have the greatest potential benefit when people are treated earlier in their disease, and we are working hard in partnership with others to improve detection and diagnosis," sheThe FDA's decision was welcomed by the Alzheimer's Association, a non-profit organization focused on eradication of...

"Having multiple treatment options is the kind of advancement we've all been waiting for – all of us who have been touched, even blindsided, by this difficult and devastating disease,"In Alzheimer's disease, two key proteins, tau and amyloid beta, build up into tangles and plaques, known together as aggregates, which cause brain cells to die and lead to brain shrinkage.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves new Alzheimer's treatment, donanemab from Eli LillyFDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
Source: CBSNews - 🏆 87. / 68 Read more »

FDA approves Eli Lilly's Alzheimer’s drug that slows memory declineBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

FDA approves Eli Lilly Alzheimer's drug, expanding treatment options in U.S.Donanemab will compete head-to-head with another treatment from Biogen and its Japanese partner Eisai called Leqembi
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »

US FDA approves Eli Lilly Alzheimer's drug that slows progress of the diseaseThe U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly’s LLY.N donanemab for patients with early Alzheimer’s, making it the second approved drug for slowing th…
Source: nypost - 🏆 91. / 67 Read more »

FDA approves Eli Lilly’s Alzheimer’s drug KisunlaBerkeley Lovelace Jr. is a health and medical news reporter for NBC News.
Source: TODAYshow - 🏆 389. / 55 Read more »